课题基金 / 基金详情

INNATE IMMUNITY OF ENTEROCYTOZOON BIENEUSI (EB) IN VIVO

INNATE IMMUNITY OF ENTEROCYTOZOON BIENEUSI (EB) IN VIVO
肠细胞虫 BIENEUSI (EB) 体内的先天免疫
批准号:
7715540
负责人:
SAUL r TZIPORI
金额:
$5.52万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-05 至 2009-04-30

项目摘要

项目成果

SAUL r TZIPORI的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 从SIV感染的动物收集粪便,分析EB孢子的存在,从中纯化EB孢子,用于对这种寄生虫的实验室研究,这种寄生虫在SIV感染的动物中更常见。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The feces were collected from SIV-infected animals and were analyzed for the presence of EB spores from which they were purified for laboratory investigations on this parasite which occurs more frequently in SIV infected animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF INNATE IMMUNITY TO ENTEROCYTOZOON BIENEUSI INFECTION
  • 批准号:
    7958373
  • 项目类别:
  • 资助金额:
    $11.19万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
Development of Aptamer-Based Therapy Against HUS
  • 批准号:
    7644745
  • 项目类别:
  • 资助金额:
    $68.11万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
Development of Aptamer-Based Therapy Against HUS
  • 批准号:
    7929518
  • 项目类别:
  • 资助金额:
    $66.47万
  • 财政年份:
    2009
  • 负责人:
    SAUL r TZIPORI
  • 依托单位:
CONTRIBUTION OF OIS TO INTESTINAL DYSFUNCTION AND WASTING
  • 批准号:
    7562006
  • 项目类别:
  • 资助金额:
    $10.36万
  • 财政年份:
    2007
  • 负责人:
    SAUL r TZIPORI
  • 依托单位: